-
公开(公告)号:EP2897611B1
公开(公告)日:2019-07-24
申请号:EP13773463.8
申请日:2013-09-17
申请人: AbbVie Inc.
发明人: NG, Teresa (lok-Chan) , PILOT-MATIAS, Tami J. , KATI, Warren M. , KRISHNAN, Preethi , MARING, Clarence J. , MISTRY, Neeta C. , REISCH, Thomas J. , WAGNER, Rolf , LIU, Dachun , PRATT, John K. , MATULENKO, Mark A. , KEDDY, Ryan G.
IPC分类号: A61K31/4184 , A61P31/14
-
公开(公告)号:EP2897612A1
公开(公告)日:2015-07-29
申请号:EP13773464.6
申请日:2013-09-17
申请人: AbbVie Inc.
发明人: KRISHNAN, Preethi , NG, Teresa (lok-Chan) , PILOT-MATIAS, Tami J. , KATI, Warren M. , MARING, Clarence J. , MISTRY, Neeta C. , REISCH, Thomas J. , WAGNER, Rolf , LIU, Dachun , PRATT, John K. , MATULENKO, Mark A. , KEDDY, Ryan G.
IPC分类号: A61K31/4184 , A61P31/14
CPC分类号: A61K31/454 , A61K31/4184 , A61K45/06 , A61K2300/00
摘要: Pan-genotypic HCV inhibitors are described. This invention also relates to methods of using these inhibitors to treat HCV infection.
-
公开(公告)号:EP2897611A1
公开(公告)日:2015-07-29
申请号:EP13773463.8
申请日:2013-09-17
申请人: AbbVie Inc.
发明人: NG, Teresa (lok-Chan) , PILOT-MATIAS, Tami J. , KATI, Warren M. , KRISHNAN, Preethi , MARING, Clarence J. , MISTRY, Neeta C. , REISCH, Thomas J. , WAGNER, Rolf , LIU, Dachun , PRATT, John K. , MATULENKO, Mark A. , KEDDY, Ryan G.
IPC分类号: A61K31/4184 , A61P31/14
CPC分类号: A61K31/454 , A61K31/4184 , A61K45/06 , A61P31/14 , A61K2300/00
摘要: Pan-genotypic HCV inhibitors are described. This invention also relates to methods of using these inhibitors to treat HCV infection.
摘要翻译: 描述了泛基因型HCV抑制剂。 本发明还涉及使用这些抑制剂治疗HCV感染的方法。
-
公开(公告)号:EP2651925A2
公开(公告)日:2013-10-23
申请号:EP11849149.7
申请日:2011-12-15
申请人: Abbvie Inc.
发明人: KRUEGER, Allan C. , KATI, Warren M. , MARING, Clarence J. , WAGNER, Rolf , HUTCHINS, Charles W.
IPC分类号: C07D403/14 , C07D401/12 , C07D403/04 , A61K31/4427 , A61P31/12
CPC分类号: C07D403/14 , A61K31/4427 , C07D401/14
摘要: The present invention relates to anti-HCV compounds, compositions comprising the same and methods of using the same to treat HCV infection.
摘要翻译: 本发明涉及抗HCV化合物,包含其的组合物以及使用该化合物治疗HCV感染的方法。
-
公开(公告)号:EP2627651A1
公开(公告)日:2013-08-21
申请号:EP11773371.7
申请日:2011-10-12
申请人: Abbvie Inc.
发明人: DEGOEY, David A. , KATI, Warren M. , HUTCHINS, Charles W. , DONNER, Pamela L. , KRUEGER, Allan C. , RANDOLPH, John T. , MOTTER, Christopher E. , NELSON, Lissa T. , PATEL, Sachel V. , MATULENKO, Mark A. , KEDDY, Ryan G. , JINKERSON, Tammie K. , GAO, Yi , LIU, Dachun , PRATT, John K. , ROCKWAY, Todd W. , MARING, Clarence J. , HUTCHINSON, Douglas K. , FLENTGE, Charles A. , WAGNER, Rolf , TUFANO, Michael D. , BETEBENNER, David A. , SARRIS, Kathy , WOLLER, Kevin R. , WAGAW, Sebel H. , CALIFANO, Jean C. , LI, Wenke , CASPI, Daniel D. , BELLIZZI, Mary E. , CARROLL, William A.
IPC分类号: C07D403/14
CPC分类号: A61K31/4184 , A61K31/4178 , A61K31/422 , A61K31/435 , A61K31/4355 , A61K31/438 , A61K31/4418 , A61K31/4439 , A61K31/454 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/695 , A61K45/06 , C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D453/00 , C07D491/113 , C07F7/02 , Y02P20/582
摘要: Compounds effective in inhibiting replication of Hepatitis C virus (HCV) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
摘要翻译: 描述了有效抑制丙型肝炎病毒(HCV)复制的化合物。 本发明还涉及制备这些化合物的方法,包含这些化合物的组合物,以及使用这些化合物治疗HCV感染的方法。
-
-
-
-